Simran Rehani
Stories (4/0)
Rising Acute Respiratory Distress Syndrome (ARDS) Prevalence Posing a Major Public Health Concern
Acute Respiratory Distress Syndrome (ARDS) Prevalence Acute respiratory distress syndrome (ARDS) is more common each year; it is predicted that 190,000 Americans alone will receive an ARDS diagnosis this year. More than 700,000 people in the US and 2 million instances worldwide had ARDS before the COVID-19 global pandemic, with a 40% cumulative mortality rate due to trauma, sepsis, bacterial, and viral infections. Because neither SARS-CoV-2 immunizations nor anti-SARS-CoV-2 vaccines address the uncontrolled inflammation that encourages multiorgan failure and ARDS death, the COVID-19 pandemic has brought to light numerous serious unmet requirements in the ARDS domain.
By Simran Rehaniabout a year ago in Humans
How are Neurostimulation Devices Playing a Vital Role in the Treatment of Chronic Pain?
Neurostimulation Devices In the United States, around 50 Million suffer from chronic pain. Chronic pain prevalence has grown significantly over the past few decades due to lifestyle changes, traumatic injury, growth in the overweight or obese population, and a rise in critical surgeries, among several other underlying health conditions.
By Simran Rehani2 years ago in Humans
Evaluation of the Advancing Developmental and Epileptic Encephalopathy Treatment Pipeline
Developmental and Epileptic Encephalopathy (DEE) is a term used to describe a category of severe epilepsies that are marked by severe developmental delays or possibly the loss of developmental skills in addition to seizures that are frequently drug-resistant. Cognitive processes are significantly impacted by seizures, interictal epileptiform activity, and the neurobiological basis of epilepsy in Developmental and Epileptic Encephalopathy. The onset of Developmental and Epileptic Encephalopathy (DEEs), which are also linked to gene variations, typically occurs in infancy. The time of brain maturation during which the seizures occur, which in turn depends on other factors, such as underlying pathology, genetic susceptibility factors, and seizure triggers, has an impact on cognitive function to some extent (e.g., febrile illness). While seizures are not always a direct cause of cognitive impairments, it is crucial to understand that seizures can potentially contribute to the development of cognitive impairments.
By Simran Rehani2 years ago in FYI
Fungal Pneumonia Market Report 2032 | DelveInsight
DelveInsight's "Fungal Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fungal Pneumonia, historical and forecasted epidemiology as well as the Fungal Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
By Simran Rehani2 years ago in Humans